Doximity, Inc. $DOCS Shares Acquired by Rhenman & Partners Asset Management AB

Posted by Francis Steltz on Jun 13th, 2026

Rhenman & Partners Asset Management AB grew its holdings in Doximity, Inc. (NYSE:DOCS – Free Report) by 174.1% during the 4th quarter, HoldingsChannel.com reports. The firm owned 372,750 shares of the company’s stock after buying an additional 236,750 shares during the period. Doximity accounts for approximately 1.5% of Rhenman & Partners Asset Management AB’s holdings, making the stock its 23rd largest holding. Rhenman & Partners Asset Management AB’s holdings in Doximity were worth $16,505,000 at the end of the most recent quarter.

Several other large investors have also modified their holdings of DOCS. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in Doximity by 0.5% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 38,978 shares of the company’s stock worth $2,262,000 after purchasing an additional 210 shares in the last quarter. BOKF NA grew its stake in Doximity by 5.3% during the 3rd quarter. BOKF NA now owns 5,356 shares of the company’s stock worth $392,000 after purchasing an additional 269 shares in the last quarter. Northwestern Mutual Investment Management Company LLC grew its stake in Doximity by 1.1% during the 4th quarter. Northwestern Mutual Investment Management Company LLC now owns 30,736 shares of the company’s stock worth $1,361,000 after purchasing an additional 333 shares in the last quarter. Wealth Alliance LLC grew its stake in Doximity by 8.0% during the 3rd quarter. Wealth Alliance LLC now owns 5,124 shares of the company’s stock worth $375,000 after purchasing an additional 378 shares in the last quarter. Finally, Lifestyle Asset Management Inc. grew its stake in Doximity by 5.9% during the 4th quarter. Lifestyle Asset Management Inc. now owns 7,083 shares of the company’s stock worth $314,000 after purchasing an additional 396 shares in the last quarter. Institutional investors and hedge funds own 87.19% of the company’s stock.

Insider Activity

In other news, insider Siddharth Sitaram sold 2,444 shares of the company’s stock in a transaction dated Monday, June 8th. The stock was sold at an average price of $20.41, for a total transaction of $49,882.04. Following the completion of the transaction, the insider directly owned 90,706 shares of the company’s stock, valued at approximately $1,851,309.46. This represents a 2.62% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Kira Scherer Wampler sold 9,000 shares of the company’s stock in a transaction dated Thursday, May 7th. The stock was sold at an average price of $26.06, for a total value of $234,540.00. Following the transaction, the director directly owned 19,839 shares of the company’s stock, valued at approximately $517,004.34. This represents a 31.21% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders have sold 16,180 shares of company stock valued at $395,110. Insiders own 31.30% of the company’s stock.

Doximity Trading Up 0.0%

NYSE:DOCS opened at $20.02 on Friday. The business’s 50-day simple moving average is $22.30. The firm has a market cap of $3.66 billion, a PE ratio of 20.22, a P/E/G ratio of 3.41 and a beta of 1.30. Doximity, Inc. has a 1 year low of $17.15 and a 1 year high of $76.51.

Analyst Upgrades and Downgrades

Several research firms recently commented on DOCS. Evercore cut Doximity from an “outperform” rating to an “in-line” rating and set a $25.00 target price for the company. in a research note on Wednesday, April 8th. Royal Bank Of Canada reissued an “outperform” rating and set a $44.00 target price on shares of Doximity in a research note on Monday, March 9th. Barclays reissued an “equal weight” rating and set a $20.00 target price (down from $38.00) on shares of Doximity in a research note on Thursday, May 14th. BMO Capital Markets lowered their price objective on Doximity from $25.00 to $20.00 and set a “market perform” rating for the company in a research report on Thursday, May 14th. Finally, Bank of America lowered their price objective on Doximity from $56.00 to $47.00 and set a “buy” rating for the company in a research report on Thursday, April 16th. Two equities research analysts have rated the stock with a Strong Buy rating, seven have issued a Buy rating, twelve have given a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat, Doximity has an average rating of “Hold” and an average price target of $30.62.

Get Our Latest Report on DOCS

Doximity Company Profile

(Free Report)

Doximity, trading as DOCS, operates a digital professional network and communications platform designed primarily for clinicians. Headquartered in San Francisco, the company connects physicians, nurse practitioners, physician assistants and other healthcare professionals, providing tools that streamline clinical communication, telehealth delivery and access to specialty-specific medical information. Its platform is positioned as a professional hub where clinicians manage their workflows, stay current with medical news and collaborate securely with peers.

The company’s offerings include secure messaging and video telehealth capabilities that enable clinicians to consult with patients and colleagues while protecting patient information.